News Scientists finally reveal how this Alzheimer’s drug really works Lecanemab, marketed as Leqembi, is a monoclonal antibody treatment for Alzheimer’s disease that targets and removes harmful amyloid plaques while slowing cognitive decline. Scientists... therapy-today.com6 hours ago